WO2000070079A8 - High throughput assay for modulators of nuclear receptors - Google Patents

High throughput assay for modulators of nuclear receptors

Info

Publication number
WO2000070079A8
WO2000070079A8 PCT/US2000/012863 US0012863W WO0070079A8 WO 2000070079 A8 WO2000070079 A8 WO 2000070079A8 US 0012863 W US0012863 W US 0012863W WO 0070079 A8 WO0070079 A8 WO 0070079A8
Authority
WO
WIPO (PCT)
Prior art keywords
nuclear receptors
modulators
high throughput
throughput assay
estrogen receptor
Prior art date
Application number
PCT/US2000/012863
Other languages
French (fr)
Other versions
WO2000070079A1 (en
Inventor
George F Allan
Joanna Clancy
Amy Hutchins
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Priority to AU48385/00A priority Critical patent/AU4838500A/en
Publication of WO2000070079A1 publication Critical patent/WO2000070079A1/en
Publication of WO2000070079A8 publication Critical patent/WO2000070079A8/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743Steroid hormones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/20Screening for compounds of potential therapeutic value cell-free systems

Abstract

Herein we describe the design and use of a scintillation proximity-based assay for screening compounds for estrogen receptor binding. The estrogen receptor exists in two forms, α and β, and is a target for preventing osteoporosis and other post-menopausal conditions, and for treating breast cancer. The methods described herein can easily be adapted for use with other nuclear receptors where at least one ligand is known.
PCT/US2000/012863 1999-05-13 2000-05-10 High throughput assay for modulators of nuclear receptors WO2000070079A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU48385/00A AU4838500A (en) 1999-05-13 2000-05-10 High throughput assay for modulators of nuclear receptors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31179799A 1999-05-13 1999-05-13
US09/311,797 1999-05-13

Publications (2)

Publication Number Publication Date
WO2000070079A1 WO2000070079A1 (en) 2000-11-23
WO2000070079A8 true WO2000070079A8 (en) 2001-02-08

Family

ID=23208519

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/012863 WO2000070079A1 (en) 1999-05-13 2000-05-10 High throughput assay for modulators of nuclear receptors

Country Status (3)

Country Link
AR (1) AR023985A1 (en)
AU (1) AU4838500A (en)
WO (1) WO2000070079A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL159819A0 (en) 2001-07-13 2004-06-20 Janssen Pharmaceutica Nv Cardiovascular safety assay

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568649A (en) * 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
US5312752A (en) * 1989-07-31 1994-05-17 Trustees Of Boston University Specific antibodies against the DNA-binding domain of and immunoassays to determine the presence and functional status of estrogen receptor proteins
US5512429A (en) * 1989-09-19 1996-04-30 British Technology Group Limited Assay for enzyme activity
US5783398A (en) * 1995-09-15 1998-07-21 Merck & Co., Inc. High throughput assay using fusion proteins

Also Published As

Publication number Publication date
AR023985A1 (en) 2002-09-04
AU4838500A (en) 2000-12-05
WO2000070079A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
HK1033126A1 (en) Non-steroidal ligands for the estrogen receptor.
AU1199600A (en) Estrogen receptor ligands
ZA200201053B (en) Bicyclic androgen and progesterone receptor modulator compounds and methods.
HK1054345A1 (en) Method and apparatus for making particle-embedded webs.
AU5047800A (en) Breast, gastric and prostate cancer associated antigens and uses therefor
EP1049946A4 (en) Composite nanophosphor screen for detecting radiation
AU1229000A (en) Assays for ligands for nuclear receptors
MXPA01011294A (en) Tetracyclic progesterone receptor modulator compounds and methods.
EP1023437A4 (en) Receptor kinase, bin1
WO2000070079A8 (en) High throughput assay for modulators of nuclear receptors
ZA200107343B (en) Concrete mixing drum fin structure.
WO1998057982A3 (en) Aib1, a steroid receptor co-activator
AU3364899A (en) Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
WO1998056812A3 (en) Estrogen receptor crystals and ligands
WO1999041608A3 (en) Interaction between cyclin d1 and steroid receptor co-activators
AU1286399A (en) 3-aminoalkylamino- 2h-1,4-benzoxazines and 3-aminoalkylamino- 2h-1,4-benzothiazines: dopamine receptor subtype specific ligands
ID23653A (en) BREAST CANCER PREVENTION WITH SELECTIVE ESTROGENT RECEPTOR MODULATORS
EP0989566A4 (en) Radiation intensifying paper, and radiation receptor and radiation inspection apparatus using the paper
AU2459597A (en) N-aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands
ZA995029B (en) Estrogen agonists/antagonists.
AU2335797A (en) Novel n-aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands
AU1177899A (en) Screening for analytes using labeled receptors
MXPA01011286A (en) Cyclocarbamate derivatives as progesterone receptor modulators.
AU4337499A (en) Substituted thienocycloalkylpyrazoles: dopamine receptor subtype specific ligands
AU4038399A (en) Method and device for filling capsules with flat structures, especially bags

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WR Later publication of a revised version of an international search report
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

CFP Corrected version of a pamphlet front page

Free format text: REVISED ABSTRACT RECEIVED BY THE INTERNATIONAL BUREAU AFTER COMPLETION OF THE TECHNICAL PREPARATIONS FOR INTERNATIONAL PUBLICATION

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP